Sequential re-rating: management describes the same offering landing bigger the second and third time around
The model's full reasoning — Q4 2023 call → NOThe question asks whether management describes that successive engagements of the same kind are coming in at progressively larger size. I need to look for evidence in the transcript where management conveys that the unit size of its repeatable business is escalating. Let me scan the transcript for relevant statements. The main topics discussed are: auto production, EV content, industrial equipment destocking, communications/AI ramps, etc. Key passages to examine: 1. On AI: "we saw a sequential growth in orders in our fiscal fourth quarter due to early ramps of artificial intelligence programs" - this is about order growth, not necessarily deal size. 2. On AI pipeline: "last quarter, we talked about $1 billion of pipeline wins even in just where we've gone to up to $1.3 billion in just three months." - This is about pipeline wins increasing, but is this about the size of individual deals or just more wins? It says "pipeline wins" went from $1 billion to $1.3 billion. This could be interpreted as more wins or bigger wins, but it's not clearly about the unit size of each engagement. 3. On AI: "you saw earlier ramps than even we expected" - again, about timing, not size. 4. On EV content: "we generate approximately 2x the content in electric vehicle platforms versus combustion engine vehicles" - this is about content per vehicle, but this is a known structural fact, not an escalation over time. 5. On Transportation: "we continue to expect four to six points of outgrowth versus the market due to the content we're going to get" - this is about growth, not deal size escalation. 6. On Communications: "we continue to expect volume growth from AI applications as we move through 2024" - volume growth, not size. 7. On the AI programs: "we think they'll build up as we go through the year and they can be well over $100 million of incremental revenue contribution through the year" - this is about revenue contribution, not deal size. 8. On the AI ramps: "we had our second consecutive quarter of sequential order growth which is being driven by new orders for artificial intelligence applications" - again, order growth, not deal size. Now, is there any statement about the individual size of deals, orders, contracts, projects, customers, sites, or programs being bigger than before? I don't see any explicit statement about deal size escalation.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| ASO | Academy Sports and Outdoors, Inc. | Q1 2024 | 2024-06-11 | C+ |
| AKYA | Akoya Biosciences, Inc. | Q2 2023 | 2023-08-07 | C+ |
| SPT | Sprout Social, Inc. | Q2 2023 | 2023-08-04 | B+ |
| SGRY | Surgery Partners, Inc. | Q2 2022 | 2022-08-02 | B+ |
| CYBR | CyberArk Software Ltd. | Q3 2021 | 2021-11-04 | B+ |
| ASAN | Asana, Inc. | Q2 2022 | 2021-09-01 | B+ |
| OWL | Blue Owl Capital Inc. | Q2 2021 | 2021-08-10 | B+ |
AKYA · Q2 2023 → YESThe question is: Does management describe that the company's SUCCESSIVE ENGAGEMENTS OF THE SAME KIND ARE COMING IN AT PROGRESSIVELY LARGER SIZE? YES The transcript shows management describing a clear pattern of escalating project sizes in the translational/clinical space. Brian notes a migration from exploratory studies (reasonable size) to larger retrospective studies and even larger retrospective-prospective ongoing clinical studies, with projects moving "further and further downstream.
ASAN · Q2 2022 → YESThe question is: Does management describe that the company's SUCCESSIVE ENGAGEMENTS OF THE SAME KIND ARE COMING IN AT PROGRESSIVELY LARGER SIZE? YES Management describes exactly this pattern. Dustin notes the company is “closing larger deals and expanding seats across departments and geographies quickly in large organizations,” and that the growth in the >$50k cohort “reflected an acceleration in our largest enterprise customers.
SGRY · Q2 2022 → YESThe question is: Does management describe that the company's SUCCESSIVE ENGAGEMENTS OF THE SAME KIND ARE COMING IN AT PROGRESSIVELY LARGER SIZE? YES The transcript shows management describing exactly this pattern for physician recruiting cohorts. Wayne notes that the 2022 cohorts are “no exception to this trend, bringing more cases with a higher overall net revenue per case than our 2021 cohorts did in the same period last year.